ReviewTherapeutic advances in neurological disorders2023

Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?

Felix Kohle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.